ADL- Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT ID: NCT00887705

Last Updated: 2010-06-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2010-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ADL training of copd patients results in better execution of activities of daily living.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1: Standard rehabilitation programme

Group Type NO_INTERVENTION

No interventions assigned to this group

2. Additional ADL training

Group Type EXPERIMENTAL

ADL training

Intervention Type BEHAVIORAL

The control group gets the standard rehabilitation programme which includes one hour ADL- training. The experimental group also gets the standard rehabilitation program, but instead of one hour they get an additional five hours ADL- training.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ADL training

The control group gets the standard rehabilitation programme which includes one hour ADL- training. The experimental group also gets the standard rehabilitation program, but instead of one hour they get an additional five hours ADL- training.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COPD
* Referred for rehabilitation
* Age \> 18 years
* Symptoms affecting ADL function
* 6 minute walk distance (6MWD) \< 400 meters

Exclusion Criteria

* Patients who smokes or has smoked during the last three months.
* LTOT
* Patients who has another disability
* Patients who can't read or speak Norwegian
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

LHL Helse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Glittreklinikken

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Morten S Ryg, Dr philos

Role: STUDY_DIRECTOR

LHL Helse

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Glittreklinikken

Hakadal, Akershus, Norway

Site Status

Glittreklinikken

Hakadal, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Related Links

Access external resources that provide additional context or updates about the study.

http://www.lhl.no

Site of LHL (Norwegian association for lung and heart disease patients). Glittreklinikken is listed as part of the organization

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GK-63

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.